BioTuring
BioTuring is a San Diego bioinformatics software company (founded 2016) that sells an integrated ecosystem of platforms — BBrowserX Pro, SpatialX, Talk2Data, and SmartBulk — for single-cell, multi-omics, and spatial biology analysis, serving academic researchers and pharmaceutical enterprises globally.
- Company typePrivate
- Founded2016
- HeadquartersSan Diego, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What BioTuring does
BioTuring, Inc. is a San Diego-based bioinformatics software company founded in 2016 that develops an integrated ecosystem of platforms for single-cell, multi-omics, and spatial biology data analysis. Its product family includes BBrowserX Pro for large-scale single-cell RNA-seq analysis (handling 10M+ cells), SpatialX for spatial transcriptomics and proteomics, Talk2Data (a GPU-accelerated database of 500M+ curated single cells with natural-language agentic AI queries and Model-Context-Protocol interoperability on NVIDIA Blackwell B200 infrastructure), SmartBulk for bulk RNA-seq, BioVinci for visualization, BioStudio as an all-in-one notebook platform, BioTuring Lens for spatial deconvolution, and the BioFlex Python SDK for programmatic access. Underlying technology combines proprietary deep-learning algorithms (Venice, IC-VAE, MetaReference, AlphaSC) with multi-stage data curation pipelines standardized on EBI Cell Ontology, Mondo Disease Ontology, and UBERON.
The company serves individual academic researchers, postdoctoral fellows, and professors at universities and academic medical centers (Chiba University, Stanford Medicine, MD Anderson, University of Tokyo, CWRU, University of Hawaii) alongside enterprise customers including pharmaceutical companies (Sanofi, via the Sanofi Browser on Talk2Data for neurodegenerative disease datasets) and biotech services firms (Argentys). BioTuring is certified to ISO/IEC 27001 (2019) and ISO/IEC 27701 (2022).
BioTuring generates revenue primarily through annual software subscriptions across multiple Subscription Levels (SaaS, private-cloud, on-premise), tiered project-based data curation services (price tiers from under $20k to over $1M covering spatial, single-cell, pathology, bulk, and ATAC-Seq annotation), and professional services for implementation, training, and support. Go-to-market blends a product-led growth motion with free trials and self-serve access for individual researchers, complemented by enterprise field sales for pharmaceutical and large research institution contracts. The company is privately held, CEO-led by Son Pham, with only $1,020,677 in disclosed funding from October 2017.
BioTuring firmographics
Firmographics- Name
- BioTuring
- Legal name
- BioTuring, Inc.
- Website
- https://bioturing.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioTuring is a San Diego bioinformatics software company (founded 2016) that sells an integrated ecosystem of platforms — BBrowserX Pro, SpatialX, Talk2Data, and SmartBulk — for single-cell, multi-omics, and spatial biology analysis, serving academic researchers and pharmaceutical enterprises globally.
- Ownership category
- akta.pro rank
BioTuring industry classification
Industry- Product category
- Bioinformatics Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industries
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE)
Keywords
Where BioTuring is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BioTuring business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- Software Subscriptions: BioTuring grants customers limited, non-exclusive, non-transferable, non-sublicensable subscription rights to access and use the software platforms (BBrowserX, SpatialX, Talk2Data, SmartBulk, BioVinci) during a defined subscription term. Subscriptions are assigned to specific customer or Authorized User accounts and may include various Subscription Levels with different feature entitlements, user counts, storage parameters, and support scope. Fees are non-cancellable and non-refundable once paid, with invoices due within 30 days.
- Professional Services: Implementation, onboarding, maintenance, support, training, hosting, migration, storage, compute, and related professional or technical services provided under separate Order Forms. Custom implementations, bespoke onboarding, and expanded support scope are billed separately through Order Forms.
- Data Curation Services: Tailored data curation solutions for biological data including radiological imaging, spatial omics, single-cell annotation, pathology image annotation, bulk annotation, and ATAC-Seq curation. Pricing is project-based with tiers: <$20k, $20k-100k, $100k-1M, $1M+.
- Trial Services: Trial, proof-of-concept, sandbox, pilot, evaluation, or no-charge access to software or services provided for customer internal evaluation purposes. Trial services are modified or limited at BioTuring's discretion and do not include service commitments or enhanced support obligations.
- Data Storage Services: Right to store and process Customer Data in specified amounts and retention profiles as identified in Order Forms or Subscription plans, with additional storage billed separately.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Data Curation Services - Project Budget Tiers |
| Subscription | Annual | Subscription Levels |
| Freemium | Pay-as-you-go | Trial Services |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
BioTuring product offering
Product offeringCore offering
BioTuring develops and sells a suite of bioinformatics software platforms for analyzing single-cell, spatial, and bulk RNA-sequencing data. Its core offerings include BBrowserX Pro for large-scale single-cell analysis, SpatialX for spatial biology data, Talk2Data as a GPU-accelerated database of 500M+ curated single cells, and SmartBulk for bulk RNA-seq analysis, complemented by professional data curation services.
Product overview
BioTuring offers a unified ecosystem of bioinformatics platforms and services for multi-omics and spatial biology analysis. The core portfolio includes BBrowserX Pro for large-scale single-cell RNA-sequencing analysis (handling 10M+ cells), SpatialX for spatial biology data analysis with cell annotation, Talk2Data as a GPU-accelerated database of 500M+ curated single-cell profiles with natural language AI queries, and SmartBulk for bulk RNA-sequencing analysis. Additional products include BioVinci for visualization, BioStudio as an all-in-one bioinformatics platform, BioTuring Lens for spatial deconvolution, and the BioFlex SDK for programmatic access. The ecosystem is complemented by data curation services including spatial annotation, single-cell annotation, pathology image annotation, bulk annotation, and ATAC-Seq annotation. The company holds ISO/IEC 27001 and ISO/IEC 27701 certifications and has partnered with industry leaders including Sanofi for the Sanofi Browser collaboration on Talk2Data.
Differentiator
Problem solved
Functional benefit
Brands
- BBrowserX Pro: An all-in-one platform for analysis of single-cell RNA-sequencing data with advanced tools for cell type annotation, DGE analysis, and cell-cell communication
- SpatialX
- Talk2Data
- SmartBulk
- BioVinci
- BioStudio
- BioTuring Lens
- BioFlex SDK
Products and services
- BBrowserX Pro An all-in-one platform for analyzing single-cell RNA-sequencing data, handling giga-scale studies exceeding 10M cells with integrated annotation, automated cell type prediction, differential gene expression analysis, pathway enrichment, cell-cell communication analysis, pseudotime/trajectory analysis, and cancer cell prediction modules. Designed for biomedical researchers and scientists.
- SpatialX A platform for analyzing spatial biology data with cell annotation, enabling exploration of spatial transcriptomics data within tissue architecture context. Features a Windows-based, non-coding interface allowing biologists to interpret spatial data and understand cell-to-cell interactions at single-cell transcriptomics level.
- Talk2Data A GPU-accelerated multi-omics database providing real-time analysis of 500M+ curated single cells across multiple omics layers. Features natural language queries with agentic AI trained on biomedical knowledge, BioFlex SDK for programmatic access, and Model-Context-Protocol interoperability for AI agent integration.
- SmartBulk An intuitive platform for analyzing bulk RNA-sequencing data, enabling identification of differentially expressed genes, enriched pathways, sample clustering, and cell-type deconvolution. Includes PCA analysis and functional enrichment capabilities.
- BioFlex SDK A Python-based software development kit providing programmatic access to Talk2Data datasets, enabling execution of analyses and embedding BioTuring platform capabilities into custom computational pipelines.
- Data Curation Services Professional data curation services including Spatial Annotation Service, Single-Cell Annotation Service, Pathology Image Annotation Service, Bulk Annotation Service, and ATAC-Seq Annotation Service. Services organize, normalize, and annotate biological data using standardized ontologies for downstream analysis. Priced by project budget tiers from under $20k to over $1M.
Quantifiable outcome
- Handles giga-scale studies exceeding 10M cells while staying responsive
- +3 more outcomes
Companies that use BioTuring
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
BioTuring technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature13 records
BioTuring partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SanoficoreBioTuring hosts the Sanofi Browser on its Talk2Data platform, providing access to Sanofi's published single-cell transcriptomic datasets (5 studies with 297,364 cells total) focused on neurodegenerative disease research including ALS, multiple sclerosis, and Parkinson's disease models. The collaboration enables researchers to explore Sanofi's published datasets including microglia ferroptosis studies (Ryan et al.), BTK inhibitor research (Gruber et al.), and RIPK1 signaling studies in ALS (Zelic et al.).
Scale indicators17 records
Recent moves6 records
Expansion highlights5 records
BioTuring competitors and assessment
Company assessmentDirect peers
- Partek (Illumina): Direct competitor in single-cell and bulk RNA-seq analysis software. Now owned by Illumina, Partek offers FlowJo and Partek Flow with similar cell-type annotation, DGE, and visualization capabilities targeted at bench scientists without heavy coding requirements.
- Qlucore: Direct peer in GUI-driven omics analysis software for life sciences. Qlucore offers multi-omics, single-cell, and spatial visualization tools with a similar non-coding positioning aimed at biologists and translational researchers.
- Dotmatics: Scientific informatics platform serving biology R&D with data analysis, visualization, and ELN capabilities. Overlaps with BioTuring on multi-omics data analysis and pharma/biotech enterprise workflows, with broader lab informatics scope.
- Biomage (now part of Parse Biosciences): Cloud-based single-cell RNA-seq analysis platform directly competing with BBrowserX Pro. Acquired by Parse Biosciences, Biomage targets bench scientists with no-code analysis workflows similar to BioTuring's positioning.
- Visiopharm: Spatial biology and pathology image analysis software serving translational and clinical research. Directly comparable to BioTuring's SpatialX and pathology image annotation services for tissue-based spatial workflows.
Emerging players
- LatchBio: Cloud-native bioinformatics platform offering data management, analysis pipelines, and AI tools for multi-omics and biomedical data. Overlaps with BioTuring's Talk2Data and BioStudio offerings with a stronger developer/AI-agent focus.
- Owkin: AI platform connecting multimodal biomedical data with pharma research workflows. Comparable to BioTuring's Talk2Data in curating and querying large-scale multi-omics datasets with AI/ML, though with a stronger focus on federated learning and biopharma partnership economics.
- Immunai: AI-driven immunology platform built on single-cell and multi-omics data, serving pharma drug discovery. Comparable to BioTuring's cell-type annotation and pharma positioning, with a deeper immunology-specific focus.
Broad incumbents
- SOPHiA Genetics: AI-driven genomics and multimodal data analysis platform serving hospitals, labs, and pharma. Overlaps with BioTuring in multi-omics analysis and pharma R&D workflows but with a broader clinical/diagnostic orientation and larger installed base.
Others
- GenePattern / SeqGeq (Broad Institute / FlowJo): Open-source and academic bioinformatics platforms (GenePattern) and SeqGeq single-cell analysis software target similar single-cell and multi-omics workflows as BioTuring, primarily through academic distribution channels.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
BioTuring social profiles
Digital presenceBioTuring compliance and trust
Trust signalCompliance2 records
BioTuring financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioTuring leadership team
Management profileNumber of profiles
Profiles1 record
BioTuring funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioTuring M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioTuring
What does BioTuring do?
BioTuring develops and sells a suite of bioinformatics software platforms for analyzing single-cell, spatial, and bulk RNA-sequencing data. Its core offerings include BBrowserX Pro for large-scale single-cell analysis, SpatialX for spatial biology data, Talk2Data as a GPU-accelerated database of 500M+ curated single cells, and SmartBulk for bulk RNA-seq analysis, complemented by professional data curation services.
Is BioTuring a public or private company?
BioTuring is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BioTuring founded?
BioTuring was founded in 2016. It employs 11 to 50 people.
Where is BioTuring based?
BioTuring is headquartered in San Diego, United States, in the North America region.
How does BioTuring make money?
Five revenue lines are on record. Software Subscriptions are the primary driver. The others are professional Services, data Curation Services, trial Services and data Storage Services.
Who are BioTuring's main competitors?
Direct peers on record are Partek (Illumina), Qlucore, Dotmatics, Biomage (now part of Parse Biosciences) and Visiopharm. Emerging players are LatchBio, Owkin and Immunai. SOPHiA Genetics is listed as a broad incumbent. GenePattern / SeqGeq (Broad Institute / FlowJo) is listed as an others.
Does BioTuring have an API?
Yes. Talk2Data provides the BioFlex SDK for programmatic access to datasets, running analyses, and embedding Talk2Data into custom computational pipelines. Talk2Data also offers Model-Context-Protocol interoperability for AI agent integration. The SDK enables programmatic access to 500M+ curated single-cell and multi-omics profiles. Developer documentation is at bioturing.com/documentation.
What industry is BioTuring in?
BioTuring's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 5132 and its SIC code is 7372.